HOME ABOUT PRODUCTS FACILITIES CONTACT US NEWSROOM PHARMACOVIGILANCE Product Development Aspar are pleased to announce that it has received Licenses for the following products and has embarked on packaging concepts. Paracetamol Soluble Cystitis Relief Antacid Tablets MHRA News Aspar have just been granted it’s own license for ASPAR Hayfever & Allergy Relief 10mg Tablets (cetirizine hydrochloride) CLICK HERE TO REPORT A PROBLEM OR FOR MEDICAL ASSISTANCE Aspar Pharmaceuticals Ltd Albany House Acrewood Way St Albans AL4 0JY Tel: 020 8205 9846 Fax: 020 8205 9854 Email: info@aspar.co.uk Registered in England No: 2658906 VAT Registered No: GB 587 0621 24

HOME ABOUT PRODUCTS FACILITIES CONTACT US NEWSROOM PHARMACOVIGILANCE Pharmacovigilance Patient safety is of utmost importance to ASPAR Pharmaceuticals. Pharmacovigilance relates to the detection, assessment, understanding and prevention of the adverse effects or any other drug related problems. While medicines have led to major improvement in the treatment and control of disease, all may cause side effects in some people. Company Responsibilities ASPAR Pharmaceuticals is responsible for the continued monitoring of the safety of their products. To manage these responsibilities companies must fulfill a number of obligations including the collection and investigation of information relating to side-effects of their medicines, and reporting adverse events to the regulatory authorities within strict timelines. Information from spontaneous reports provided by health professionals and patients is of great value during the regular reviews of the safety profile of ASPAR products, and enables the provision of a better service to health professionals and patients enquiring about side-effects and toxicity. CLICK HERE TO REPORT A PROBLEM OR FOR MEDICAL ASSISTANCE Aspar Pharmaceuticals Ltd Albany House Acrewood Way St Albans AL4 0JY Tel: 020 8205 9846 Fax: 020 8205 9854 Email: info@aspar.co.uk Registered in England No: 2658906 VAT Registered No: GB 587 0621 24